Literature DB >> 33099847

MicroRNA-206 inhibits influenza A virus replication by targeting tankyrase 2.

Gayan Bamunuarachchi1,2, Xiaoyun Yang1,2, Chaoqun Huang1,2, Yurong Liang1,2, Yujie Guo, Lin Liu1,2.   

Abstract

Due to the frequent mutations, influenza A virus (IAV) becomes resistant to anti-viral drugs targeting influenza viral proteins. There are increasing interests in anti-viral agents that target host cellular proteins required for virus replication. Tankyrase (TNKS) has poly (ADP-ribose) polymerase activity and is a negative regulator of many host proteins. The objectives of this study are to study the role of TNKS2 in IAV infection, identify the microRNAs targeting TNKS2, and to understand the mechanisms involved. We found that TNKS2 expression was elevated in human lung epithelial cells and mouse lungs during IAV infection. Knock-down of TNKS2 by RNA interference reduced viral replication. Using a computation approach and 3'-untranslation regions (3'-UTR) reporter assay, we identified miR-206 as the microRNA that targeted TNKS2. Overexpression of miR-206 reduced viral protein levels and virus production in cell culture. The effect of miR-206 on IAV replication was strain-independent. miR-206 activated JNK/c-Jun signalling, induced type I interferon expression and enhanced Stat signalling. Finally, the delivery of an adenovirus expressing miR-206 into the lung of mice challenged with IAV increased type I interferon response, suppressed viral load in the lungs and increased survival. Our results indicate that miR-206 has anti-influenza activity by targeting TNKS2 and subsequently activating the anti-viral state.
© 2020 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33099847      PMCID: PMC8279255          DOI: 10.1111/cmi.13281

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  55 in total

Review 1.  Bottleneck limitations for microRNA-based therapeutics from bench to the bedside.

Authors:  Yan Chen; Hongliang Zhao; Zhijun Tan; Cuiping Zhang; Xiaobing Fu
Journal:  Pharmazie       Date:  2015-03       Impact factor: 1.267

Review 2.  Current and next generation influenza vaccines: Formulation and production strategies.

Authors:  Peter C Soema; Ronald Kompier; Jean-Pierre Amorij; Gideon F A Kersten
Journal:  Eur J Pharm Biopharm       Date:  2015-06-03       Impact factor: 5.571

3.  Differential expression of serum microRNAs in cirrhosis that evolve into hepatocellular carcinoma related to hepatitis B virus.

Authors:  Youwen Tan; Bin Lin; Yun Ye; Danfeng Wen; Li Chen; Xinbei Zhou
Journal:  Oncol Rep       Date:  2015-04-24       Impact factor: 3.906

Review 4.  Influenza virus evolution, host adaptation, and pandemic formation.

Authors:  Jeffery K Taubenberger; John C Kash
Journal:  Cell Host Microbe       Date:  2010-06-25       Impact factor: 21.023

5.  Cellular microRNAs inhibit replication of the H1N1 influenza A virus in infected cells.

Authors:  Liping Song; He Liu; Shijuan Gao; Wei Jiang; Wenlin Huang
Journal:  J Virol       Date:  2010-06-16       Impact factor: 5.103

Review 6.  The biology of influenza viruses.

Authors:  Nicole M Bouvier; Peter Palese
Journal:  Vaccine       Date:  2008-09-12       Impact factor: 3.641

7.  p-STAT1 regulates the influenza A virus replication and inflammatory response in vitro and vivo.

Authors:  Shouping Zhang; Caiyun Huo; Jin Xiao; Tao Fan; Shumei Zou; Peng Qi; Lunquan Sun; Ming Wang; Yanxin Hu
Journal:  Virology       Date:  2019-08-25       Impact factor: 3.616

8.  Regulation of influenza virus replication by Wnt/β-catenin signaling.

Authors:  Sunil More; Xiaoyun Yang; Zhengyu Zhu; Gayan Bamunuarachchi; Yujie Guo; Chaoqun Huang; Keith Bailey; Jordan P Metcalf; Lin Liu
Journal:  PLoS One       Date:  2018-01-11       Impact factor: 3.240

9.  Annual estimates of the burden of seasonal influenza in the United States: A tool for strengthening influenza surveillance and preparedness.

Authors:  Melissa A Rolfes; Ivo M Foppa; Shikha Garg; Brendan Flannery; Lynnette Brammer; James A Singleton; Erin Burns; Daniel Jernigan; Sonja J Olsen; Joseph Bresee; Carrie Reed
Journal:  Influenza Other Respir Viruses       Date:  2018-02-14       Impact factor: 4.380

Review 10.  MicroRNA-206: a promising theranostic marker.

Authors:  Jan Novák; Peter Kružliak; Julie Bienertová-Vašků; Ondřej Slabý; Miroslav Novák
Journal:  Theranostics       Date:  2014-01-02       Impact factor: 11.556

View more
  2 in total

Review 1.  Promising use of immune cell-derived exosomes in the treatment of SARS-CoV-2 infections.

Authors:  Murad Alahdal; Eyad Elkord
Journal:  Clin Transl Med       Date:  2022-08

Review 2.  Host Non-Coding RNA Regulates Influenza A Virus Replication.

Authors:  Yuejiao Liao; Shouqing Guo; Geng Liu; Zhenyu Qiu; Jiamin Wang; Di Yang; Xiaojing Tian; Ziling Qiao; Zhongren Ma; Zhenbin Liu
Journal:  Viruses       Date:  2021-12-29       Impact factor: 5.048

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.